November 30, 2023
Behind China’s Plans to Build AI for the World
This fall, the Western world has galvanized around a blitz of AI initiatives, statements and multilateral deals — not least the Biden administration’s executive order and the U.K.’s Bletchley declaration — all geared to setting global rules for a fast-moving, competitive and possibly dangerous new technology.
China is taking a different path, one that could give it a lead while the West talks.
To compete with China’s efforts, the United States needs a far more expansive vision of how to empower other nations with the education, tools and infrastructure needed to jump start their own AI efforts
Rather than competing with the West to write the rules of the road for AI, Beijing is instead building the road itself, working with allies and client nations to construct Chinese-built AI ecosystems that could pose global risks if they take root and expand.
Read the full article and more from POLITICO Magazine.
More from CNAS
-
Biotech Matters: Public-Private Coordination of Biotechnology
Reports
An appreciation of biotechnology’s great opportunities is, for many commentators, intimately joined with regret about a disconnect between the U.S. government and the private ...
By Richard Danzig
-
$6.6 billion TSMC deal in Arizona the latest in the CHIPS Act’s rollout
Podcast
“President Biden signed the CHIPS and Science Act just about 20 months ago, which in government time is yesterday. And they’ve hired 200 people,” said Vivek Chilukuri, a senio...
By Vivek Chilukuri
-
Response to NTIA Request for Comment: “Dual Use Foundation Artificial Intelligence Models with Widely Available Model Weights”
Commentary
In February 2024, the Department of Commerce’s National Telecommunications and Information Administration (NTIA) issued a Request for Comment (RFC) on the implications of “ope...
By Caleb Withers
-
Biotech Matters: Great Data Competition and Interoperability with Allies and Partners
Reports
Understanding and strengthening America’s biotechnology leadership requires exploring the limits of existing data relevant to the U.S. bioeconomy so that policymakers and the ...
By Michelle Holko
